New anticancer drug class.
D002648:Child; D005047:Etoposide / Q000627:therapeutic use*; D006801:Humans; D007880:Legislation, Drug; D009369:Neoplasms / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000627:therapeutic use*; D014481:United States
D005047:Etoposide; D013713:Teniposide; D011034:Podophyllotoxin